Literature DB >> 16091486

The metabolic syndrome, insulin resistance, and cardiovascular risk in diabetic and nondiabetic patients.

Christoph H Saely1, Stefan Aczel, Thomas Marte, Peter Langer, Guenter Hoefle, Heinz Drexel.   

Abstract

CONTEXT: The contribution of insulin resistance per se to the vascular risk conferred by the metabolic syndrome (MetS) is not known; conversely, it is uncertain whether insulin resistance confers vascular risk beyond the entity of the MetS.
OBJECTIVE: The objective of this study was to investigate the impact of the MetS (Adult Treatment Panel III criteria) and insulin resistance (as estimated by the homeostasis model assessment index) on the incidence of vascular events. DESIGN AND PATIENTS: This was a prospective cohort study enrolling 750 consecutive patients undergoing coronary angiography for the evaluation of coronary artery disease.
SETTING: The study was performed at a tertiary care clinical research center. MAIN OUTCOME MEASURE: The main outcome measure was the incidence of vascular events over 2.3 yr.
RESULTS: Both the MetS and insulin resistance predicted vascular events after controlling for non-MetS risk factors [hazard ratio (HR), 2.74 (95% confidence interval, 1.71-4.39; P < 0.001) and 1.51 (1.24-1.84; P < 0.001), respectively]. After additional adjustment for insulin resistance, the MetS remained significantly predictive of vascular events [HR, 2.69 (1.57-4.64); P < 0.001], and conversely, insulin resistance remained significantly predictive of vascular events despite adjustment for the MetS [standardized HR, 1.41 (1.14-1.75); P = 0.002]. Additional adjustment for the presence of type 2 diabetes revealed that both the MetS [adjusted HR, 2.57 (1.47-4.51); P = 0.001] and homeostasis model assessment of insulin resistance [standardized adjusted HR, 1.37 (1.09-1.73); P = 0.007] significantly predicted vascular events independent from diabetes status.
CONCLUSIONS: Both the MetS and insulin resistance are strong and mutually independent predictors of vascular risk among angiographed coronary patients.

Entities:  

Mesh:

Year:  2005        PMID: 16091486     DOI: 10.1210/jc.2005-0799

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  45 in total

1.  Insulin resistance: Is it time for primary prevention?

Authors:  Valentina Mercurio; Guido Carlomagno; Valeria Fazio; Serafino Fazio
Journal:  World J Cardiol       Date:  2012-01-26

2.  Relationship between neck circumference and overactive bladder in women with metabolic syndrome: a preliminary study.

Authors:  Yigit Akin; Hakan Gulmez; Murat Savas; Serdar Aykan; Ozde Onder; Selcuk Yucel
Journal:  Wien Klin Wochenschr       Date:  2015-04-09       Impact factor: 1.704

3.  Associations of total osteocalcin with all-cause and cardiovascular mortality in older men. The Health In Men Study.

Authors:  B B Yeap; S A P Chubb; L Flicker; K A McCaul; P R Ebeling; G J Hankey; J P Beilby; P E Norman
Journal:  Osteoporos Int       Date:  2011-02-26       Impact factor: 4.507

Review 4.  The role of androgens and estrogens on healthy aging and longevity.

Authors:  Astrid M Horstman; E Lichar Dillon; Randall J Urban; Melinda Sheffield-Moore
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-26       Impact factor: 6.053

Review 5.  [Lipid therapy in patients with diabetes].

Authors:  Christoph H Saely; Heinz Drexel
Journal:  Wien Med Wochenschr       Date:  2010-01

6.  Impaired contractile recovery after low-flow myocardial ischemia in a porcine model of metabolic syndrome.

Authors:  Janice V Huang; Li Lu; Shuyu Ye; Bryan C Bergman; Genevieve C Sparagna; Mohammad Sarraf; Jane E B Reusch; Clifford R Greyson; Gregory G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-01-18       Impact factor: 4.733

7.  Cardiovascular risk factors in primary hyperparathyroidism.

Authors:  R Luboshitzky; Y Chertok-Schaham; I Lavi; A Ishay
Journal:  J Endocrinol Invest       Date:  2009-04       Impact factor: 4.256

8.  Multiple abnormalities of myocardial insulin signaling in a porcine model of diet-induced obesity.

Authors:  Jenny Lee; Ya Xu; Li Lu; Bryan Bergman; J Wayne Leitner; Clifford Greyson; Boris Draznin; Gregory G Schwartz
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-11-06       Impact factor: 4.733

9.  PI3K-resistant GSK3 controls adiponectin formation and protects from metabolic syndrome.

Authors:  Hong Chen; Abul Fajol; Miriam Hoene; Bingbing Zhang; Erwin D Schleicher; Yun Lin; Carsten Calaminus; Bernd J Pichler; Cora Weigert; Hans U Häring; Florian Lang; Michael Föller
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-02       Impact factor: 11.205

Review 10.  Bipolar disorder and the metabolic syndrome: causal factors, psychiatric outcomes and economic burden.

Authors:  Andrea Fagiolini; K N Roy Chengappa; Isabella Soreca; Jane Chang
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.